Immutep (IMMP) Long-Term Debt Repayments (2016 - 2023)

Immutep (IMMP) posted Long-Term Debt Repayments of $1.5 million for Q2 2023, up 1473.37% on a QoQ basis from $97746.3 in Q2 2016.

Immutep (IMMP) Long-Term Debt Repayments (2016 - 2023) Analysis & Trends

Immutep's Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at $1.5 million for Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	7.64 Mn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Immutep	569.08 Mn	569.08 Mn	-	-

Download Data